Early Convalescent Plasma for COVID-19 Does Not Result in Faster Symptom Resolution
Researchers assessed the effects of convalescent vs control plasma on time to symptom resolution among patients with COVID-19 infection.
Diagnosis & Disease Information
COVID-19 Vaccine Protection Lasts at Least Six Months After Second Dose
Vaccine effectiveness against death was lower for patients aged 80 years and older.
Uptake Low for COVID-19 Vaccine Boosters in Immunocompromised Adults
Authors found low adherence to CDC recommendations for boosters, with older adults more likely to receive at least four mRNA COVID-19 vaccine doses.
Bivalent COVID-19 Vaccine May Not Protect Cancer Patients From Current Variants
Pfizer-BioNTech’s bivalent COVID-19 vaccine may not protect cancer patients from the most common omicron subvariant in circulation now, a study suggests.
Vaccination Coverage Down in Kindergarteners During 2021 to 2022
Vaccination coverage decreased 0.4 to 0.9 percent compared with the 2020 to 2021 school year.
Vaccines Do Not Reduce the Risk of Severe COVID-19 Among Cancer Patients Receiving Certain Therapies
COVID-19 vaccines did not reduce the risk of severe COVID-19 among cancer patients who received radiation, CAR T-cell therapy, or HSCT.
Overall Increase Seen in COVID-19 Vaccine Acceptance Globally
Vaccine hesitancy varied considerably; 12.1 percent of vaccinated individuals hesitant about booster doses.
Increasing Staff Vaccination at Nursing Homes Cuts COVID-19 Infections
Increase in vaccination rate linked to fewer COVID-19 cases and deaths among residents, cases among staff.
COVID-19 Vaccination Bests Natural Immunity for Cutting Death, Hospitalizations
However, natural immunity tied to lower incidence of new infection.
Safety Signal in Seniors Prompts Investigation of Bivalent COVID-19 Vaccine
The preliminary safety signal was identified by the CDC’s Vaccine Safety Datalink.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...